Agilon Health, Inc. insider trading
Every open-market purchase and sale by Agilon Health, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Agilon Health, Inc.’s insiders pay?
From September 14, 2021 to March 3, 2026, 18 insiders reported 10 open-market purchases and 23 sales not made under a pre-set plan in Agilon Health, Inc. Twelve months after each purchase was reported, the shares were −91.7% against the S&P 500 on average (median −114.4%), over 3 purchases with a full year of prices; 0% beat the index. After sales, the shares moved −20.5% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on November 23, 2022 into $1,512 by November 2, 2026, −38.3% a year. It held shares 51% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $16,681 (+14.0% a year), and held throughout $19,799 (+19.1%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Shaker Benjamin | Chief Markets Officer | 1 | — | — | 4 | +9.1% (4) | March 3, 2026 |
| Wulf John William | Director | 2 | — | — | 3 | −29.4% (3) | January 30, 2026 |
| Sell Steven | CEO & President | 3 | −80.4% (2) | 0% | 1 | −6.2% (1) | September 16, 2024 |
| Cd&r Investment Associates Ix, Ltd. | 10% owner | 0 | — | — | 2 | −65.5% (2) | May 18, 2023 |
| Danieley Joan | Chief Administrative Officer | 0 | — | — | 2 | −18.6% (2) | December 21, 2021 |
| Desai Veeral | Chief Strategy & Dev. Officer | 0 | — | — | 2 | +12.8% (2) | March 18, 2022 |
| Kornitzer Benjamin | Chief Med. & Quality Officer | 0 | — | — | 2 | −59.9% (2) | March 17, 2023 |
| Battaglia Silvana | Director | 1 | — | — | 0 | — | December 13, 2024 |
| Cd&r Vector Holdings, L.P. | 10% owner | 0 | — | — | 1 | −7.9% (1) | September 14, 2021 |
| Dombro Lisa | Exper. & Innovation Officer | 0 | — | — | 1 | −6.2% (1) | September 15, 2021 |
| Gertsch Timothy | Chief Accounting Officer | 0 | — | — | 1 | −108.5% (1) | September 13, 2023 |
| Halkias Theodore | Chief Business Officer | 0 | — | — | 1 | −6.2% (1) | September 15, 2021 |
| Mansukani Sharad | Director | 0 | — | — | 1 | −6.2% (1) | September 15, 2021 |
| Mckenzie Diana | Director | 1 | — | — | 0 | — | December 11, 2024 |
| Mcloughlin Karen | Director | 1 | — | — | 0 | — | December 13, 2024 |
| Schwaneke Jeffrey A. | Director | 1 | −114.4% (1) | 0% | 0 | — | November 30, 2023 |
| Smith Michael L | Director | 0 | — | — | 1 | −3.0% (1) | May 27, 2022 |
| Sobotka Glenn | Chief Accounting Officer | 0 | — | — | 1 | −12.4% (1) | November 12, 2021 |
When several insiders traded Agilon Health, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Agilon Health, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 2 buying crowds with six months of prices, it averaged +409.4% against the index. After 3 selling crowds, −17.5%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| March 31, 2026 | 2 buying | +1297.7% | +888.3% | not yet |
| December 29, 2023 | 2 buying | −69.0% | −69.4% | −109.7% |
| May 31, 2023 | 3 selling | −16.1% | −55.8% | −96.3% |
| March 31, 2022 | 3 selling | +4.4% | +12.6% | +7.5% |
| September 30, 2021 | 9 selling | −7.1% | −9.2% | +4.9% |